Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy
Authors
Keywords
-
Journal
Therapeutic Advances in Chronic Disease
Volume 8, Issue 4-5, Pages 81-91
Publisher
SAGE Publications
Online
2017-03-24
DOI
10.1177/2040622317700822
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis
- (2016) Roy A. Pleasants et al. DRUGS
- Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
- (2016) Dave Singh et al. LANCET
- Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
- (2016) Chris Kalberg et al. Drugs in research & development
- A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD
- (2016) Gregory Feldman et al. International Journal of Chronic Obstructive Pulmonary Disease
- The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study
- (2016) Ana R Sousa et al. npj Primary Care Respiratory Medicine
- Vilanterol trifenatate for the treatment of COPD
- (2016) Mario Malerba et al. Expert Review of Respiratory Medicine
- A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD
- (2015) Gustavo J. Rodrigo et al. CHEST
- Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers
- (2015) Noushin Brealey et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial
- (2015) Chaoying Hu et al. PLoS One
- Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD
- (2014) Bartolome Celli et al. CHEST
- Population Pharmacokinetics of Inhaled Umeclidinium and Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
- (2014) Navin Goyal et al. CLINICAL PHARMACOKINETICS
- A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects
- (2014) Dennis Kelleher et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial
- (2014) M. Reza Maleki-Yazdi et al. RESPIRATORY MEDICINE
- Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
- (2014) Marc Decramer et al. Lancet Respiratory Medicine
- Novel anti-cholinergics in COPD
- (2013) A. Prakash et al. DRUG DISCOVERY TODAY
- Umeclidinium in patients with COPD: a randomised, placebo-controlled study
- (2013) R. Trivedi et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
- (2013) J.F. Donohue et al. RESPIRATORY MEDICINE
- Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study
- (2013) Rashmi Mehta et al. International Journal of Chronic Obstructive Pulmonary Disease
- Muscarinic Receptors and Their Antagonists in COPD: Anti-Inflammatory and Antiremodeling Effects
- (2012) George Karakiulakis et al. MEDIATORS OF INFLAMMATION
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Umeclidinium and Vilanterol Alone and in Combination: A Randomized Crossover Trial
- (2012) Dennis L. Kelleher et al. PLoS One
- A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD
- (2012) James F. Donohue et al. RESPIRATORY MEDICINE
- Comparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: A systematic review
- (2011) Gustavo J. Rodrigo et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Heparin Induces Rat Aorta Relaxation via Integrin-Dependent Activation of Muscarinic M 3 Receptors
- (2010) Edgar J. Paredes-Gamero et al. HYPERTENSION
- Synthesis and Structure−Activity Relationships of Long-acting β2Adrenergic Receptor Agonists Incorporating Metabolic Inactivation: An Antedrug Approach
- (2010) Panayiotis A. Procopiou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Unknown
- (2010) G. Villetti et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Mono- and Combination Therapy of Long-Acting Bronchodilators and Inhaled Corticosteroids in Advanced COPD
- (2010) Jill Ohar et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey
- (2009) Martyn R. Partridge et al. CURRENT MEDICAL RESEARCH AND OPINION
- COPD: what is the unmet need?
- (2008) P M A Calverley BRITISH JOURNAL OF PHARMACOLOGY
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
- (2008) Donald P. Tashkin et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now